Medical Gas Therapy Practice Test

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that includes emphysema and chronic bronchitis. In patients with COPD, the body often adapts to chronically low levels of oxygen (hypoxia) and high levels of carbon dioxide (hypercapnia). This adaptation can lead to a shift in the drive to breathe from a low oxygen level to a high carbon dioxide level.

When supplemental oxygen is provided to patients with COPD, there is a risk of reducing this hypoxic drive to breathe, which can lead to respiratory depression or even respiratory failure. Therefore, careful monitoring of oxygen levels is essential to avoid exceeding recommended oxygen saturation levels, usually targeted at 88-92% in these patients. Maintaining these levels helps ensure that the patient's respiratory drive remains intact while providing adequate oxygenation.

In contrast, conditions such as asthma typically do not involve the same risk of respiratory depression from supplemental oxygen, as patients do not have the same underlying issues with chronic carbon dioxide retention. Pneumonia can cause acute respiratory distress but is usually treated with supportive therapies rather than cautious oxygen administration. Anemia involves low levels of hemoglobin affecting oxygen transport but doesn't typically lead to concerns about respiratory drive in relation to oxygen therapy.